Author:
Midtvedt Karsten,Fauchald Per,Lien Bjoern,Hartmann Anders,Albrechtsen Dagfinn,Bjerkely Birgitte L.,Leivestad Torbjoern,Brekke Inge B.
Reference20 articles.
1. The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy;Norman;Am J Kidney Dis,1988
2. Preliminary results of prospective randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early post-operative period;Hesse;Transplant Proc,1990
3. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients;Mariat;Transpl Int,1998
4. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobuline with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection;Casadei;Transplantation,2001
5. Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection;Midtvedt;Transplantation,1996
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献